Cargando…
Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer
Oral mucositis (OM) is a common adverse effect of docetaxel-containing treatment. This study aimed to assess whether dexamethasone (DEX) dose-dependently attenuates docetaxel-induced OM and dysgeusia. We retrospectively analyzed medical records of patients with breast cancer receiving docetaxel-cont...
Autores principales: | Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Oshino, Tomohiro, Sugawara, Mitsuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287713/ https://www.ncbi.nlm.nih.gov/pubmed/37349388 http://dx.doi.org/10.1038/s41598-023-37285-9 |
Ejemplares similares
-
Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2022) -
High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2023) -
Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2021) -
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2021) -
Combination of Mirogabalin and Duloxetine Attenuates Peripheral Neuropathy by Eribulin: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2022)